Literature DB >> 29626648

Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.

Meina Wu1, Fang Zhou2, Xiuli Cao2, Junting Yang2, Yu Bai2, Xudong Yan2, Jimin Cao2, Jinshun Qi2.   

Abstract

Circadian rhythm disturbance (CRD) is one of the iconic manifestations in Alzheimer's disease (AD), a disease tightly associated with age, but the characteristics and gender difference of CRD occurred in AD have not been well demonstrated. Using 6-month-old triple transgenic AD mouse model (3xTg-AD) without obvious brain pathological changes, we demonstrated the gender difference of CRD at this age. We further showed abnormal Per gene expression in the central clock suprachiasmatic nucleus (SCN) of the 3xTg-AD mice. Specifically, compared with the wide type (WT) mice, the 3xTg-AD mice showed disrupted circadian locomotor rhythms both at LD (light-dark 12 h:12 h) and DD (constant dark) conditions, such as increased activities in the resting phase, decreased and scattered activities in the active phase, decreased overall activity intensities, amplitude, robustness, and increased intradaily variability. We further observed that 3xTg-AD female mice showed obviously less CRD compared with the 3xTg-AD male mice, and female mice of both WT and 3xTg-AD were more active in locomotor activity. Accordingly, 3xTg-AD mice showed a phase delay in the expression of Per1 and Per2 mRNA in the SCN, with the levels of Per1 and Per2 mRNA were significantly lower than that of WT mice at specific time points. We conclude that 3xTg-AD mice exhibit behavioral CRD at the age of six months with male gender preference, and these phenomena are at least partly associated with the alteration of Per1 and Per2 transcription patterns in the SCN.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease (AD); Circadian rhythm; Locomotor activity; Per1; Per2; Triple-transgenic AD (3xTg-AD) mice

Mesh:

Substances:

Year:  2018        PMID: 29626648     DOI: 10.1016/j.neulet.2018.04.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 2.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

3.  Deletion of the Capn1 Gene Results in Alterations in Signaling Pathways Related to Alzheimer's Disease, Protein Quality Control and Synaptic Plasticity in Mouse Brain.

Authors:  Wenyue Su; Qian Zhou; Yubin Wang; Athar Chishti; Qingshun Q Li; Sujay Dayal; Shayan Shiehzadegan; Ariel Cheng; Clare Moore; Xiaoning Bi; Michel Baudry
Journal:  Front Genet       Date:  2020-04-09       Impact factor: 4.599

4.  Clock/Sleep-Dependent Learning and Memory in Male 3xTg-AD Mice at Advanced Disease Stages and Extrinsic Effects of Huprine X and the Novel Multitarget Agent AVCRI104P3.

Authors:  Lydia Giménez-Llort; Mikel Santana-Santana; Míriam Ratia; Belén Pérez; Pelayo Camps; Diego Muñoz-Torrero; Albert Badia; Maria Victòria Clos
Journal:  Brain Sci       Date:  2021-03-26

5.  Simultaneous Alteration of the Circadian Variation of Memory, Hippocampal Synaptic Plasticity, and Metabolism in a Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  António M Carvalho da Silva; Cristina Lemos; Henrique B Silva; Ildete L Ferreira; Angelo R Tomé; A Cristina Rego; Rodrigo A Cunha
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

Review 6.  Evaluating Circadian Dysfunction in Mouse Models of Alzheimer's Disease: Where Do We Stand?

Authors:  Patrick W Sheehan; Erik S Musiek
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.